These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19646406)

  • 21. Evaluation of the Safety and Immune Efficacy of Recombinant Human Respiratory Syncytial Virus Strain Long Live Attenuated Vaccine Candidates.
    Wang LN; Peng XL; Xu M; Zheng YB; Jiao YY; Yu JM; Fu YH; Zheng YP; Zhu WY; Dong ZJ; He JS
    Virol Sin; 2021 Aug; 36(4):706-720. PubMed ID: 33559831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations.
    Juhasz K; Whitehead SS; Boulanger CA; Firestone CY; Collins PL; Murphy BR
    Vaccine; 1999 Mar; 17(11-12):1416-24. PubMed ID: 10195777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure.
    Le Nouën C; McCarty T; Brown M; Smith ML; Lleras R; Dolan MA; Mehedi M; Yang L; Luongo C; Liang B; Munir S; DiNapoli JM; Mueller S; Wimmer E; Collins PL; Buchholz UJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E386-E395. PubMed ID: 28049853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization.
    Le Nouën C; Brock LG; Luongo C; McCarty T; Yang L; Mehedi M; Wimmer E; Mueller S; Collins PL; Buchholz UJ; DiNapoli JM
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13169-74. PubMed ID: 25157129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.
    Stobart CC; Rostad CA; Ke Z; Dillard RS; Hampton CM; Strauss JD; Yi H; Hotard AL; Meng J; Pickles RJ; Sakamoto K; Lee S; Currier MG; Moin SM; Graham BS; Boukhvalova MS; Gilbert BE; Blanco JC; Piedra PA; Wright ER; Moore ML
    Nat Commun; 2016 Dec; 7():13916. PubMed ID: 28000669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.
    Collins PL; Murphy BR
    Proc Am Thorac Soc; 2005; 2(2):166-73. PubMed ID: 16113487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children.
    McFarland EJ; Karron RA; Muresan P; Cunningham CK; Perlowski C; Libous J; Oliva J; Jean-Philippe P; Moye J; Schappell E; Barr E; Rexroad V; Fearn L; Cielo M; Wiznia A; Deville JG; Yang L; Luongo C; Collins PL; Buchholz UJ
    J Infect Dis; 2020 Jun; 221(12):2050-2059. PubMed ID: 32006006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.
    Whitehead SS; Hill MG; Firestone CY; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 1999 Dec; 73(12):9773-80. PubMed ID: 10559287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
    Buchholz UJ; Cunningham CK; Muresan P; Gnanashanmugam D; Sato P; Siberry GK; Rexroad V; Valentine M; Perlowski C; Schappell E; Thumar B; Luongo C; Barr E; Aziz M; Yogev R; Spector SA; Collins PL; McFarland EJ; Karron RA;
    J Infect Dis; 2018 Apr; 217(9):1338-1346. PubMed ID: 29509929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates.
    Mueller S; Stauft CB; Kalkeri R; Koidei F; Kushnir A; Tasker S; Coleman JR
    Vaccine; 2020 Mar; 38(14):2943-2948. PubMed ID: 32107060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein.
    Alamares-Sapuay J; Kishko M; Lai C; Parrington M; Delagrave S; Herbert R; Castens A; Swerczek J; Luongo C; Yang L; Collins PL; Buchholz UJ; Zhang L
    PLoS One; 2024; 19(4):e0301773. PubMed ID: 38593167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic stability determinants of temperature sensitive, live attenuated respiratory syncytial virus vaccine candidates.
    Lin YH; Deatly AM; Chen W; Miller LZ; Lerch R; Sidhu MS; Udem SA; Randolph VB
    Virus Res; 2006 Jan; 115(1):9-15. PubMed ID: 16099066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children.
    Karron RA; Luongo C; Mateo JS; Wanionek K; Collins PL; Buchholz UJ
    J Infect Dis; 2020 Jun; 222(1):82-91. PubMed ID: 31605113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
    Liang B; Munir S; Amaro-Carambot E; Surman S; Mackow N; Yang L; Buchholz UJ; Collins PL; Schaap-Nutt A
    J Virol; 2014 Apr; 88(8):4237-50. PubMed ID: 24478424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.
    Kotomina T; Isakova-Sivak I; Matyushenko V; Kim KH; Lee Y; Jung YJ; Kang SM; Rudenko L
    Antiviral Res; 2019 Aug; 168():9-17. PubMed ID: 31075351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus.
    Hsu KH; Crowe JE; Lubeck MD; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1995 Apr; 13(5):509-15. PubMed ID: 7543716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.
    Crowe JE; Bui PT; London WT; Davis AR; Hung PP; Chanock RM; Murphy BR
    Vaccine; 1994 Jun; 12(8):691-9. PubMed ID: 8091846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine.
    Subbarao EK; Park EJ; Lawson CM; Chen AY; Murphy BR
    J Virol; 1995 Oct; 69(10):5969-77. PubMed ID: 7666501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.